Nur so nebenbei.....curis +50% heute + gestern....... - 500 Beiträge pro Seite
eröffnet am 24.05.02 18:13:43 von
neuester Beitrag 01.06.02 09:41:17 von
neuester Beitrag 01.06.02 09:41:17 von
Beiträge: 6
ID: 590.080
ID: 590.080
Aufrufe heute: 0
Gesamt: 907
Gesamt: 907
Aktive User: 0
ISIN: US2312693094 · WKN: A3ETJD · Symbol: CRIS
14,440
USD
-0,55 %
-0,080 USD
Letzter Kurs 15:30:01 Nasdaq
Werte aus der Branche Biotechnologie
Wertpapier | Kurs | Perf. % |
---|---|---|
1,9000 | +59,66 | |
4,7450 | +35,57 | |
0,5250 | +19,08 | |
1,9700 | +15,20 | |
1,6500 | +14,58 |
Wertpapier | Kurs | Perf. % |
---|---|---|
3,4000 | -11,69 | |
11,820 | -12,18 | |
1,9500 | -25,14 | |
1,6052 | -30,21 | |
0,5121 | -30,80 |
.....nicht das ihr sagt es hätte keiner drauf hingewiesen. die anderen Biotechs schaun ja heut eher schlecht aus.....
wg. Insiderkäufe.
Vorher haben die aber gewaltigst verloren
Vorher haben die aber gewaltigst verloren
jo , low in us dollar war 1 !
... und es ist noch ein langer weg bis die hedgehog proteine
zur marktreife gelangen.
allerdings hat man mit der irischen elan auch einen ,meines
erachtens recht kompetenten partner.der auch mal unter die arme greifen
könnte , wenns eng wird.
nun , time will tell
... und es ist noch ein langer weg bis die hedgehog proteine
zur marktreife gelangen.
allerdings hat man mit der irischen elan auch einen ,meines
erachtens recht kompetenten partner.der auch mal unter die arme greifen
könnte , wenns eng wird.
nun , time will tell
Die Ursache für den Kursanstieg liegt nicht nur an der
folgenden Meldung, CRIS wurde in der Vergangenheit auch
unverhältnismäßig stark gebeutelt, ich habe dabei jedenfalls
keine fundamentalen Gründe feststellen können.
Der Aufschwung ist einfach überfällig gewesen.
Insiders Buying Shares of Curis
Updated: Thursday, May 23, 2002 09:25 AM ET Printer-friendly version
CAMBRIDGE, Mass. -(Dow Jones)- Curis Inc. (CRIS, news, msgs) noted recent purchases of its common stock by its executive officers, directors and significant current investors.
Additional information concerning the purchases wasn`t immediately available.
In a press release Thursday, Curis said the stock purchases demonstrate the investors` belief that "the recent realignment of Curis` business model will translate into increased shareholder value."
In February, Curis unveiled a plan to realign its research and development programs to focus on its proprietary signaling pathways and stem cell technologies.
Shares of Curis, which currently has about 32.2 million shares outstanding, closed Wednesday at $1.06, well below a 52-week high of $7 from August 2001. The shares hit a 52-week low of $1 in Wednesday`s trading. -Thomas Gryta; Dow Jones Newswires; 201-938-5400 (This story was originally published by Dow Jones Newswires) Copyright (c) 2002 Dow Jones & Company, Inc
Gruß BOCKNASE
folgenden Meldung, CRIS wurde in der Vergangenheit auch
unverhältnismäßig stark gebeutelt, ich habe dabei jedenfalls
keine fundamentalen Gründe feststellen können.
Der Aufschwung ist einfach überfällig gewesen.
Insiders Buying Shares of Curis
Updated: Thursday, May 23, 2002 09:25 AM ET Printer-friendly version
CAMBRIDGE, Mass. -(Dow Jones)- Curis Inc. (CRIS, news, msgs) noted recent purchases of its common stock by its executive officers, directors and significant current investors.
Additional information concerning the purchases wasn`t immediately available.
In a press release Thursday, Curis said the stock purchases demonstrate the investors` belief that "the recent realignment of Curis` business model will translate into increased shareholder value."
In February, Curis unveiled a plan to realign its research and development programs to focus on its proprietary signaling pathways and stem cell technologies.
Shares of Curis, which currently has about 32.2 million shares outstanding, closed Wednesday at $1.06, well below a 52-week high of $7 from August 2001. The shares hit a 52-week low of $1 in Wednesday`s trading. -Thomas Gryta; Dow Jones Newswires; 201-938-5400 (This story was originally published by Dow Jones Newswires) Copyright (c) 2002 Dow Jones & Company, Inc
Gruß BOCKNASE
Es sieht so aus, als könnte das Bollingerband nach oben
durchbrochen werden.
durchbrochen werden.
Ob diese Meldung zum Aktienrückkauf dem Kurs nun endlich
auf die Sprünge hilft ??
Curis Announces Stock Repurchase Program
Updated: Friday, May 31, 2002 06:43 PM ET
CAMBRIDGE, Mass.--(BW HealthWire)--May 31, 2002--Curis, Inc. (NASDAQ: CRIS, news, msgs) today announced that its Board of Directors has approved a stock repurchase program authorizing the company to buy back up to $3 million of the corporation`s common stock. Repurchases will take place on the open market from time to time based on market conditions. The repurchase program has no time limit and may be suspended for periods or discontinued.
On February 14, 2002 Curis announced that it was implementing a comprehensive realignment of its research and development programs and focusing its resources on its proprietary signaling pathways and stem cell technologies, including the Bone Morphogenic Protein (BMP) and the Hedgehog family of products. The realignment refined Curis` product focus and affected its development and clinical programs, as well as its corporate structure. Curis now deploys its resources in a highly focused manner on its core strengths driving and creating shareholder value by expediting product development in its most promising assets.
"We reiterate our full confidence in the underlying strengths and potential of Curis," said Daniel R. Passeri, President and Chief Executive Officer. "These purchases underscore our commitment to enhancing long-term shareholder value. Our reevaluation of programs based on expertise, competitive advantage, and cost efficiencies has led us to consolidate our efforts and focus on the development of drugs based on the significant opportunities we see in the signaling pathways."
auf die Sprünge hilft ??
Curis Announces Stock Repurchase Program
Updated: Friday, May 31, 2002 06:43 PM ET
CAMBRIDGE, Mass.--(BW HealthWire)--May 31, 2002--Curis, Inc. (NASDAQ: CRIS, news, msgs) today announced that its Board of Directors has approved a stock repurchase program authorizing the company to buy back up to $3 million of the corporation`s common stock. Repurchases will take place on the open market from time to time based on market conditions. The repurchase program has no time limit and may be suspended for periods or discontinued.
On February 14, 2002 Curis announced that it was implementing a comprehensive realignment of its research and development programs and focusing its resources on its proprietary signaling pathways and stem cell technologies, including the Bone Morphogenic Protein (BMP) and the Hedgehog family of products. The realignment refined Curis` product focus and affected its development and clinical programs, as well as its corporate structure. Curis now deploys its resources in a highly focused manner on its core strengths driving and creating shareholder value by expediting product development in its most promising assets.
"We reiterate our full confidence in the underlying strengths and potential of Curis," said Daniel R. Passeri, President and Chief Executive Officer. "These purchases underscore our commitment to enhancing long-term shareholder value. Our reevaluation of programs based on expertise, competitive advantage, and cost efficiencies has led us to consolidate our efforts and focus on the development of drugs based on the significant opportunities we see in the signaling pathways."
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Investoren beobachten auch:
Wertpapier | Perf. % |
---|---|
+0,55 | |
+23,94 | |
+0,86 | |
+2,25 | |
-0,18 | |
0,00 | |
+0,72 | |
-0,55 | |
0,00 | |
+0,37 |
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
240 | ||
113 | ||
107 | ||
73 | ||
57 | ||
39 | ||
37 | ||
36 | ||
34 | ||
31 |